Sun Pharma inks agreement with Takeda Pharma for commercialising Vonoprazan tablets in India

Sun Pharmaceutical Industries said that it has entered into a non-exclusive patent licensing agreement with Takeda Pharmaceutical Company (Takeda) to commercialise Vonoprazan tablets in India under the brand name "Voltapraz".